Please use this identifier to cite or link to this item: http://hdl.handle.net/2080/2146
Full metadata record
DC FieldValueLanguage
dc.contributor.authorParida, P-
dc.contributor.authorMishra, S C-
dc.contributor.authorTripathy, S P-
dc.date.accessioned2014-06-09T06:18:52Z-
dc.date.available2014-06-09T06:18:52Z-
dc.date.issued2014-
dc.identifier.citationIndo American Journal of Pharmaceutical Research,Vol 4, Issue 05, May 2014.en
dc.identifier.issn2231-6876-
dc.identifier.urihttp://hdl.handle.net/2080/2146-
dc.descriptionCopyright belongs to the Journal Articles Indo American Journal of Pharmaceutical Research.en
dc.description.abstractSimple, sensitive and specific spectrophotometric method was developed for the validation of nifedipine in tablet dosage form in two different brands. Active ingradient showed the absorption maximum in ethanol and chloroform at 235.5 nm and 235 nm respectively. The linearity was established in the concentration range of 2-10 μg/ml for nifedipine in different solvent with correlation coefficient (r2 were found to be in the range of 99.57 - 99.81 % for nifedipine in different brands. Statistically potency of two marketed brands were determined that there were no significant difference between the two brands where ANOVA at f (5,3) =196.0143 and significant level of p-value observed at 0.004. Hence the proposed method can be applied for the routine analysis of active molecule from the formulations.) of 0.997 0.999respectively.Themean % recoveriesen
dc.format.extent774510 bytes-
dc.format.mimetypeapplication/pdf-
dc.language.isoen-
dc.publisherIndo American Journal of Pharmaceutical Researchen
dc.subjectNifedipineen
dc.subjectHypertensionen
dc.subjectUv-Visibl Spectrophotometeren
dc.subjectValidationen
dc.titleSimple Spectrophatometric Method Validation Of Nifedipine Solid Dosage Formen
dc.typeArticleen
Appears in Collections:Journal Articles

Files in This Item:
File Description SizeFormat 
Patita-newpaper(1).pdf756.36 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.